Agenus Inc. (AGEN) vs Enanta Pharmaceuticals, Inc. (ENTA)
A side-by-side comparison of Agenus Inc. and Enanta Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AGEN
Agenus Inc.
$8.49HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT
ENTA
Enanta Pharmaceuticals, Inc.
$12.60HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — AGEN vs ENTA
growth of $100 · dividends reinvested · last 10yAGEN -94.1% (-24.6%/yr)ENTA -52.4% (-7.2%/yr)ENTA compounded faster over this window
Log scale — wide-divergence pair
AGEN ENTA
AGEN vs ENTA: by the numbers
- •ENTA is the larger company ($366M vs $354M market cap).
- •AGEN is profitable (69.34% net margin) while ENTA runs a net loss (-96.89%).
- •AGEN grew revenue faster over the past five years (14.13% vs -7.65% CAGR).
Metrics side by side
Valuation
| Metric | AGEN | ENTA |
|---|---|---|
| P/E ratio | 3.21 | N/A |
| Forward P/E | 31.74 | N/A |
| P/S ratio | 2.66 | 5.61 |
| P/B ratio | N/A | 3.63 |
| EV / EBITDA | 9.17 | N/A |
Profitability
| Metric | AGEN | ENTA |
|---|---|---|
| Gross margin | 29.63% | 98.15% |
| Operating margin | -18.00% | -130.65% |
| Net margin | 69.34% | -96.89% |
| ROE | N/A | -62.56% |
| ROIC | N/A | -24.20% |
Growth (annualized)
| Metric | AGEN | ENTA |
|---|---|---|
| Revenue CAGR (5Y) | 14.13% | -7.65% |
| Total return CAGR (5Y) | -40.10% | -26.94% |
Frequently asked
- Which has grown faster, AGEN or ENTA?
- Over the past five years, AGEN grew revenue faster — AGEN at a 14.13% CAGR versus ENTA at -7.65%.
- Is AGEN or ENTA more profitable?
- AGEN runs the higher net margin — AGEN at 69.34% versus ENTA at -96.89%.
- How have AGEN and ENTA total returns compared?
- Over the past 10 years, AGEN delivered -24.61% and ENTA delivered -7.11% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Agenus P/E ratioAgenus ROEEnanta Pharmaceuticals ROEAgenus operating marginEnanta Pharmaceuticals operating marginAgenus revenue growthEnanta Pharmaceuticals revenue growthAgenus free cash flowEnanta Pharmaceuticals free cash flow
Agenus & Enanta Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.